返回 Agenda
Day 2: Session 4: RBM: The Site, CRO and Pharma Perspective
Session Chair(s)
Durga A. Gadgil
Clinical Research Consultant
India
Speaker(s)
Session 4.1: Establishing Operations in RBM: The CRO Perspective
Prasida Dinesh, RPH
Chiltern Clinical Research (I) Pvt. Ltd, India
Associate Director
Session 4.2: Allergan RBM Implementation: Strategy: A Case Study
Abhijit Arun Parab, MS
Allergan, United States
Director - CDM and Programming
Session 4.3: The Critical role of the CRC in transitioning to an RBM model
Sauren Das
Excel Life Sciences Pvt. Ltd., India
Country Head & Director - Operations